期刊文献+

SSA表位在原发性干燥综合征患者唾液腺中的表达 被引量:1

Expression of SSA antigen epitopes in minor salivary glands from patients with primary Sj(o)gren's syndrome
原文传递
导出
摘要 目的 探讨60 000相对分子质量SSA表位差异性表达与原发性干燥综合征(pSS)患者唾液腺(MSG)受累的相关性.方法 利用噬菌体抗体展示技术筛选并可溶性表达针对3个SSA抗原表位(P1:480-494,P2:310-323和P3:230-241)特异性单克隆单链抗体(ScFv McAb),免疫组化法(IH)检测不同表位在pSS患者MSG的表达情况,并判断表达程度与MSG炎症是否存在相关性.结果 pSS MSG活检标本P1~P3表位的均有表达,以腺管、泌管上皮细胞胞质和胞膜着色为主.P1表位表达强度高于P2和P3表位(x2=12.94,P<0.01),且仅P1表位表达强度与MSG的炎性浸润程度呈正相关关系(t=2.27,P<0.05).结论 SSA抗原表位在MSG组织异位表达于上皮细胞的细胞膜,从而可能打破免疫耐受,诱导机体产生致病性抗体.P1表位在MSG膜高表达,而且仅P1与MSG炎症存在正相关关系,提示P1表位可能是引发pSS自身免疫应答的关键表位. Objective To investigate the correlation between the differential expression of 60 000SSA epitopes in minor salivary glands(MSG) from patients with primary Sj(o)gren's syndrome (pSS) and glandular inflammation. Methods The screening and soluble expression of single-chain fragment V monoclonal antibodies (Scfv McAb) against SSA antigen epitopes ( P1: 480-494, P2: 310-323 and P3: 230-241 )were performed by phagmid antibody expression system. The expression of epitopes was detected by immunohistochemical assay (IH) in minor salivary glands from these patients. The correlation between epitopes expression and glandular inflammation was analyzed quantitatively. Results Immunohistochemical assay of MSG with McAb against P1-P3 epitopes showed that the epithelial cells of glandular tubes and striated duct were stained in membrane and cytoplasm. The expression of P1 epitope was higher than the other two in grading score (x2 = 12. 94, P < 0. 01 ). And a positive correlation was found between the extent of glandular infiltration and the grade of P1 epitope expression(t =2. 27, P <0. 05) but not with P2 or P3 epitope. Conclusion Aberrant redistribution of intracellular SSA antigen epitopes onto the cell membrane of involved cells may break the immune tolerance and thus induce the production of pathogenic autoantibodies involved in triggering and maintaining the tissue-specific autoimmune response in pSS MSG. A significantly high membranous expression of P1 and a positive correlation between P1 and the inflammation of MSG suggest that P1 may be the dominant determinant of the antigen-driven immune response in pSS.
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第17期1187-1191,共5页 National Medical Journal of China
基金 国家自然科学基金(30471618) 国家科技支撑计划(2008BAI59B03)
关键词 表位 抗体 单链抗体 噬菌粒 Epitope Antibody Single-chain fragment V antibody Phagemid
  • 相关文献

参考文献12

  • 1张奉春,JohnB.Harley,R.HalScofield,董怡.60 kD人SSA抗原表位免疫反应的特异性[J].中华风湿病学杂志,1998,2(1):5-9. 被引量:6
  • 2Scofield AN,Kurien BT,Gordon TP,et al.Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sj(o)gron's syndrome? Lupus,2001,10:547-553.
  • 3李娅杰,刘莉,张奉春.SSA抗原及其不同阳性表位的临床意义[J].中华内科杂志,2003,42(3):165-168. 被引量:11
  • 4Barcellos KS,Nonogaki S,Enokihara MM,et al.Differential expression of Ro/SSA 60 kDa and La/SSB,but not Ro/SSA 52 kDa,mRNA and protein in minor salivary glands from patients with primary Sj(o)gren' s syndrome.J Rheumatol,2007,34:1283-1292.
  • 5Scofield RH,Asfa S,Obeso D,et al.Immunization with short peptides from the 60-kDa Ro antigen recapitulates the serological and pathological findings as well as the salivary gland dysfunction of Sjogren's syndrome.J Immunol,2005,175:8409-8414.
  • 6Reed JH,Jackson MW,Gordon TP.B cell apotopes of the 60-kDa Ro/SSA and La/SSB antoantigens.J Autoinnun,2008,31:263-267.
  • 7Lisi S,D' Amore M,Scagliusi P,et al.Anti-Ro/SSA autoantibody-mediated regulation of extracellular matrix fibulins in human epithelial cells of the salivary gland.Scand J Rheumatol,2009,38:198-206.
  • 8周炜,张奉春,唐福林,董怡.抗SSA噬菌体抗体库的构建及鉴定[J].中华风湿病学杂志,2003,7(7):394-398. 被引量:5
  • 9Gerli R,Muscat C,Giansanti M,et al.Quantitative assessment of salivary gland inflammatory infiltration in primary Sjogren' s syndrome:its relationship to different demographic,clinical and serological features of the disorder.Br J Rheumatol,1997,36:969-975.
  • 10Reksten TR,Jonsson MV,Szyszko EA,et al.Cytokine and autoantibody profiling related to histopathological features in primary Sjogren's syndrome.Rheumatology,2009,48:1102-1106.

二级参考文献13

  • 1Harley JB, Scofield RH, Reichlin M. Anti-Ro in Sjoegren's syndrome and systemic lupus erythernatosus. Rheum Dis Clin North Am,1992,18: 337-358.
  • 2Hoogenboom FIR, Chames P. Natural and designer binding sites made by phage display technology, Immunol Today,2000,21:371-378.
  • 3Welsehof M, Temess P, Kolbinger F, et al. Amino acid sequence based PCR primers for amplification of rearranged human heavy and light chain immuroglobulin variable region genes. J Immunol Methods, 1995,179: 203-214.
  • 4Wilson DR, Finlay 1313. Phage display:applications, innovations and issues in phage and host biology. Can J Microbiol, 1998, 44: 313-329.
  • 5Winter G, Griffiths AD, Hawkins RE, et al. Making antibodies by phage display technology. Annu Rev Immunol, 1994,12:433-455.
  • 6Eggena M,Targan SR, Iwanczyk L, et al. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J Immunol, 1996,156:4005-4011.
  • 7Welschof M,Temess P, Kipriyanov SM, et al. The antigen-binding domain of a human IgG-anti-F(ab') 2 autoantibody. Proc Natl Acad Sci USA, 1997,94 : 1902-1907.
  • 8Seal SN,Hoet RA, Raats JM, et al. Analysis of autoimmune bone marrow by antibody-phage display. Arthritis Rheum, 2000, 43:2132-2138.
  • 9Chukwuocha RU, Hsiao ET,Shaw P,et al. Isolation,charaterization and sequence analysis of five IgG monoclonal anti-β2-glycoprotein-1 and anti-prothrombin antigen-binding fragments generated by phage display. J Immunol, 1999,163:4604-4611.
  • 10Hoet RM, Pieffers M, Stassen MH, et al. The importance of the light chain for the epitope specificity of htanan anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients. J Immunol, 1999,163:3304-3312.

共引文献14

同被引文献7

  • 1Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet, 2003,362:53-61.
  • 2Furuya T, Tateishi M, Nishinarita M, et al. Primary biliary cirrhosis in patients with Sjogren's syndrome . Nihon Rinsho, 1995,53:2536-2539.
  • 3Heathcote EJ. Management of primary biliary cirrhosis. The american association for the Study of hver diseases practice guidelines. Hepatology ,2000,31 : 1005-1013.
  • 4Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 2002,61:554-558.
  • 5Drosos AA, Andonopoulos AP, Costopoulos JS, et al. Prevalence of primary Sjogren's syndrome in an elderly population. Br J Rheumatol, 1988,27 : 123-127.
  • 6Granito A, Muratori 19, Muratori L, et al. Antibodies to SS-A/Ro- 52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther,2007,26 : 831-838.
  • 7DSrner T, Feist E, Held C, et al. Differential recognition of the 52-kd Ro(SS-A) antigen by sera from patients with primary biliary cirrhosis and primary Sj:gren' s syndrome. Hepatology, 1996,24 : 1404-1407.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部